| Majestic Care Of Fort Wayne | |
| 7519 Winchester Rd, Fort Wayne, Indiana 46819 | |
| (260) 747-7435 | |
| Name | Majestic Care Of Fort Wayne |
|---|---|
| Location | 7519 Winchester Rd, Fort Wayne, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 66 |
| Occupancy Rate | 90% |
| Medicare ID (CCN) | 155359 |
| Legal Business Name | Daviess County Hospital |
| Ownership Type | Government - County |
| NPI Number | 1235177981 |
| Organization Name | DAVIESS COUNTY HOSPITAL |
| Doing Business As | MAJESTIC CARE OF FORT WAYNE |
| Address | 7519 Winchester Rd, Fort Wayne, IN 46819 |
| Phone Number | 260-747-7435 |
News Archive
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
TRANSCEND SERVICES, INC. a leading provider of clinical documentation services to the U.S. healthcare market, announced today that it has acquired Spryance, Inc. and its subsidiaries on October 21, 2010.
Vemma's second annual fundraising campaign for Children's Miracle Network kicks off this summer, June 1 - August 31, 2010. Funds raised will contribute to medical care, research and education throughout a network of 170 children's hospitals and foundations. Vemma NEXT, the company's liquid children's supplement, will play a key role in the fundraising effort.
SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administration for the SynCardia temporary Total Artificial Heart with SynHall valves, giving the company control over the last key component to manufacture the Total Artificial Heart.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.
TRANSCEND SERVICES, INC. a leading provider of clinical documentation services to the U.S. healthcare market, announced today that it has acquired Spryance, Inc. and its subsidiaries on October 21, 2010.
Vemma's second annual fundraising campaign for Children's Miracle Network kicks off this summer, June 1 - August 31, 2010. Funds raised will contribute to medical care, research and education throughout a network of 170 children's hospitals and foundations. Vemma NEXT, the company's liquid children's supplement, will play a key role in the fundraising effort.
SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administration for the SynCardia temporary Total Artificial Heart with SynHall valves, giving the company control over the last key component to manufacture the Total Artificial Heart.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $9100 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.11 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.57 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 27.63 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.44 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 97.61 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.23 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.91 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.67 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 38.81 | 83.88 |